Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Equipment set up in an intensive care unit
Equipment set up in an intensive care unit - Credit: sudok1 / DepositPhotos - License: DepositPhotos
Health
Coronavirus
respirator
medical mask
protective gear
vaccine
Covid-19
Covid-19 test
AstraZeneca
Hugo de Jonge
Ministry of Public Health Welfare and Sports
Thursday, 2 July 2020 - 08:51

Share this article:

Netherlands already spent billions in fight against coronavirus

Over the past few months the Netherlands already spent billions in the fight against the coronavirus, paying almost 1.5 billion euros for protective gear and other medical equipment, 700 million euros for coronavirus vaccines, and 300 million euros for tests, AD reports based on an interim change to the budget for the Ministry of Public Health, Welfare and Sports that was sent to parliament.

The bill for protective gear and medical equipment currently stands at 1.42 billion euros - 930 million euros for masks, 30 million euros for gloves, 300 million euros for insulating jackets, 10 million euros for protective glasses and weight aprons, and 150 million euros for approximately 4 thousand respirators. The government also earned 180 million euros from the sale of medical protective gear and equipment to healthcare providers.

The cabinet allocated 700 million euros for making sure that a vaccine is available to Dutch people as soon as possible. The Netherlands, Germany, France and Italy together bought 300 million vaccines from the British-Swedish pharmaceutical company Astra Zeneca. The exact costs involved in that purchase is unknown. Health Minister Hugo de Jonge will only answer questions about vaccine deals in confidential letters to parliament - letters that have since been made state secret because of "information that could seriously damage the interests of the Netherlands or its allies", according to AD.

And so far the government spent 300 million euros on testing Netherlands residents for the coronavirus. The government expects this amount to be enough to continue testing until September.

Whether these amounts will increase is "unclear at the time of writing", De Jonge said to the Tweede Kamer, the lower house of Dutch parliament.

More like this

Image
Vials of Covid-19 vaccines produced by Pfizer, Moderna and AstraZeneca. March 21, 2021
Dutch gov't did too little to prevent cronyism in buying Covid vaccines: Court of Audit
Image
New visualisation of the Covid-19 virus
Health minister not upset about rising Covid cases; Holiday parties could cause new wave
Image
A healthworker looking through a window in Hospital during the coronavirus pandemic.
Five years after first Covid-19 infection Netherlands is even less prepared for pandemic
Image
Cropped view of doctor in latex gloves holding syringe and vaccine on blurred foreground near patient
Annual Covid vaccine booster recommended for vulnerable population, healthcare workers
Make NL Times your top Google source

Follow us:

Latest stories

  • Wasteful Oranje punished as Algeria snatch late victory in World Cup warm-up
  • Dutch State buys medieval ring found with metal detector for €83,150
  • Rotterdam shooting suspect arrested in Spain within days of fleeing
  • Nearly 90% of Dutch dermatologists link TikTok skincare trends to patient skin problems
  • Dogs falling ill, dying after swimming in the IJmeer near Amsterdam & Almere

Top stories

  • Court rules Ye can remain in Netherlands for Arnhem performances this week
  • New A'dam coalition planning parking +tourist tax hike, free public transport for kids
  • European Commission tells Netherlands to stop extra border controls
  • Pregnant woman thrown to ground at Zeist asylum shelter was trying to ask cop a question
  • Senior Dutch virologist, colleague accused of smuggling inactive Mpox into United States

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content